Muramatsu, Hiroyasu
Kuramochi, Taichi
Katada, Hitoshi
Ueyama, Atsunori
Ruike, Yoshinao
Ohmine, Ken
Shida-Kawazoe, Meiri
Miyano-Nishizawa, Rie
Shimizu, Yuichiro
Okuda, Momoko
Hori, Yuji
Hayashi, Madoka
Haraya, Kenta
Ban, Nobuhiro
Nonaka, Tatsuya
Honda, Masaki
Kitamura, Hidetomo
Hattori, Kunihiro
Kitazawa, Takehisa
Igawa, Tomoyuki
Kawabe, Yoshiki
Nezu, Junichi
Article History
Received: 26 November 2020
Accepted: 8 January 2021
First Online: 25 January 2021
Competing interests
: All authors are employees of Chugai Pharmaceutical Co., Ltd. Chugai Pharmaceutical Co., Ltd. is clinically developing GYM329.